Orbital radiotherapy for thyroid eye disease
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Thyroid eye disease (TED) is seen most commonly with Graves’ disease (prevalence of 25–50%). Symptoms include diplopia, eyelid erythema and retraction, and soreness and grittiness of eyes with increased watering. Severe cases (3–5%) may present with pain, corneal ulceration, optic nerve compression and partial/total loss of vision. Corticosteroids are the primary treatment for active phase TED, although there is a risk of adverse effects such as weight gain, hypertension, and immunosuppression with long-term, high-dose use. Orbital radiotherapy (OR) is often an adjunct with steroids; this combination has provided a better response than either alone. We report a patient with moderate-to severe TED who underwent a combination of intravenous and oral steroids and orbital radiotherapy that improved her visual acuity and color vision drastically and decreased upper lid oedema.

https://goo.gl/CQMSL9
Dr. R●●a S●●●●●●●●●i and 3 others like this
Like
Comment
Share